Research – Therapy Best Practice

FOI 24/25-0247 DOCUMENT 5

Research – Therapy Best Practice

In order to develop business rules for the funding of CB supports as part of the Participant Budget Model, we need the following information: • For the following disability groups: Parkinson’s Disease, multiple sclerosis, muscular dystrophy, dementia, Huntington’s Disease, arthritis, chronic fatigue, chronic pain, amputation. • What is considered best practice in terms of: a) The allied health team members of a multidisciplinary team, i.e. who Brief should be involved in managing the disability? b) The frequency of intervention i.e. approximate dosage – how many hours per year is required for each professional? c) Evidence based practice for widely accepted therapy approaches. Not too much detail required, mainly eg “For MS, X therapy approach is often recommended, which involves intensive blocks of 20 sessions every X months”. Looking for information again regarding number of hours that would be considered best practice.

Date 28/06/21 Jane s47F - personal p - Assistant Director (TAB) s47F - personal priv Requester(s) Jean - Senior Technical Advisor (TAB) Researcher Jane s47F - personal priv - Research Team Leader (TAB)

Cleared N/A

Please note:

The research and literature reviews collated by our TAB Research Team are not to be shared external to the Branch. These are for internal TAB use only and are intended to assist our advisors with their reasonable and necessary decision-making.

Delegates have access to a wide variety of comprehensive guidance material. If Delegates require further information on access or planning matters they are to call the TAPS line for advice.

The Research Team are unable to ensure that the information listed below provides an accurate & up-to-date snapshot of these matters.

The contents of this document are OFFICIAL

1 Contents

2 Summary ……………………………………………………………………………………………………………………….. 2 3 Parkinson’s disease …………………………………………………………………………………………………………. 3 3.1 Clinician involved in management ……………………………………………………………………………… 3 3.2 Best practice treatment and frequency of intervention ………………………………………………… 3

Page 140 of 335

FOI 24/25-0247

4 Multiple sclerosis ……………………………………………………………………………………………………………. 4 4.1 Clinician involved in management ……………………………………………………………………………… 5 4.2 Best practice treatment and frequency of intervention ………………………………………………… 6 5 Muscular dystrophy ………………………………………………………………………………………………………… 7 5.1 Clinician involved in management ……………………………………………………………………………… 7 5.2 Best practice treatment and frequency of intervention ………………………………………………… 8 6 Dementia ……………………………………………………………………………………………………………………….. 9 6.1 Clinician involved in management ……………………………………………………………………………… 9 6.2 Best practice treatment and frequency of intervention ………………………………………………… 9 7 Huntington’s disease ……………………………………………………………………………………………………… 11 7.1 Clinician involved in management ……………………………………………………………………………. 11 7.2 Best practice treatment and frequency of intervention ………………………………………………. 11 8 Arthritis ……………………………………………………………………………………………………………………….. 13 9 Chronic fatigue syndrome ………………………………………………………………………………………………. 14 9.1 Clinician involved in management ……………………………………………………………………………. 15 9.2 Best practice treatment and frequency of intervention ………………………………………………. 15 10 Chronic pain ……………………………………………………………………………………………………………… 16 11 Amputation ………………………………………………………………………………………………………………. 17 11.1 Clinician involved in management ……………………………………………………………………………. 17 11.2 Best practice treatment and frequency of intervention ………………………………………………. 18 12 References ……………………………………………………………………………………………………………….. 20

2 Summary

• Information provided has been obtain from a rapid review of the literature. This includes best practice guidelines, systematic reviews from the Cochrane Collaboration and other high quality meta-analyses and reviews. • The personal circumstances, goals of each individual, and severity of the disease impacts the level of intervention required. Therefore, it is often not possible to provide an exact number of hours required for each intervention. This is reflected in the literature as studies investigating the same intervention often deliver it at a different frequency, leading to a lack of agreement around gold standard levels. • If the agency requires precise numbers around how many hours of intervention are useful per clinician they will need to commission systematic reviews of each type of intervention delivered, across various disease severities. This is a substantial tasks. Current literature

Page 141 of 335

FOI 24/25-0247

focuses on the effectiveness rather than the intensity of intervention. The level of intervention is often decided by the allied health professional looking after the patient.

3 Parkinson’s disease

3.1 Clinician involved in management

A systematic review and meta-analysis of integrated care in Parkinson’s disease provides a list of core team members to be included in interventions [1].

• Movement disorders specialist • General neurologist • PD specialist nurse • Physiotherapist • Occupational therapist • Speech therapist • Clinical psychologist • Neuropsychologist • Community mental health team • Social worker • Dietician

Models of care varied significantly, ranging from 4-8 weeks, 1-4 sessions a day (30 minutes to 2 hr per session) ranging from 1-7 days a week. No indication of what hours were allocated to each profession.

3.2 Best practice treatment and frequency of intervention

Recommendations for treatment are taken from the NICE UK guidelines [2].

1. First-line treatment a. Offer levodopa to people in the early stages of Parkinson’s disease whose motor symptoms impact on their quality of life. b. Consider a choice of dopamine agonists, levodopa or monoamine oxidase B (MAO-B) inhibitors for people in the early stages of Parkinson’s disease whose motor symptoms do not impact on their quality of life.

2. Non-pharmacological management a. Nurse specialist interventions i. Clinical monitoring and medicines adjustment. ii. A continuing point of contact for support, including home visits when appropriate.

Page 142 of 335

FOI 24/25-0247

iii. A reliable source of information about clinical and social matters of concern to people with Parkinson’s disease and their family members and their carers (as appropriate). b. Physiotherapy and physical activity [3] i. General physiotherapy: 4 weeks to 12 months. Only 2 studies reported duration of sessions which included 12 hrs over 4 weeks and 18 hrs over 6 weeks. ii. Exercise: Treatment sessions lasted from 30 minutes to two hours, and took place over a period of three to 24 weeks. iii. Treadmill: Treatment sessions lasted from 30 to 60 minutes, and took place over a period of four to eight weeks. iv. Cueing: Treatment sessions lasted from four to 30 minutes and took place over a period of a single session to 13 weeks. v. Dance: Dance classes lasted one hour over 12 to 13 weeks, with a trained instructor teaching participants the tango, waltz, or foxtrot. vi. Martial arts: Treatment lasted one hour and took place over a period of 12 to 24 weeks c. Speech and language therapy [4] i. Median duration of therapy for those treated was four weeks with 68% attending a single weekly session, a further 22%, who were predominantly receiving Lee Silverman Voice Therapy (LSVT), had four or more therapy sessions per week. Most sessions (80%) lasted between 30‐60 minutes. d. Occupational therapy [5] i. A Cochrane Review from 2007 only found 2 studies that met inclusion criteria. These studies delivered intervention of 12 hours across 4 weeks, and 20 hours over 5 weeks. e. Nutrition [6] i. Monitoring every four to six weeks if there have been any changes to medications or treatment plan, with particular focus on the swallowing recommendations. ii. Every three months if the patient’s condition is stable. iii. For oral nutrition support, regular review of ONS prescriptions every three months is advisable, to ensure the appropriateness of the intervention. iv. Some centres offer one-day holistic reviews to re-assess mobility, swallow, speech and nutritional status.

• Dysphagia management should be conducted by speech and language therapists in conjunction with nurses and dietitians. No information provided on level/duration of intervention [7].

3. Deep brain stimulation a. Surgery is performed to implant a device that sends electrical signals to brain areas responsible for body movement. Electrodes are placed deep in the brain and are connected to a stimulator device.

4 Multiple sclerosis

Page 143 of 335

FOI 24/25-0247

4.1 Clinician involved in management

There is variation in the make-up of MS multidisciplinary teams. The NICE MS Clinical Guideline states that: “As a minimum, the specialist neurological rehabilitation service should have as integral members of its team, specialist [8, 9]:

• Doctors (GPs, Neurologist) • Nurses • Physiotherapists • Occupational therapists • Speech and language therapists • Dieticians • Continence specialists • Clinical psychologists • Ophthalmologist/orthoptist • Social workers.

General rehabilitation – patients must be seen for 6-8 sessions or for a 6-8 week period, however, appointments should be booked according to the needs of the patient [8]. The figure below describes the level of dependency on specialist services for varying levels of disease severity.

Page 144 of 335

FOI 24/25-0247

4.2 Best practice treatment and frequency of intervention

Determine how often the person with MS will need to be seen based on [9]:

• Their needs, and those of their family and carers • The frequency of visits needed for different types of treatment (such as review of disease- modifying therapies, rehabilitation and symptom management). o “Review information, support and social care needs regularly”

The below interventions are listed in the NICE UK guidelines for the management of MS [9]

1. Exercise programs
2. Mindfulness-based training
3. Cognitive behavioural therapy
4. Fatigue management
5. Mobility rehabilitation
6. Spasticity management

Page 145 of 335

FOI 24/25-0247

7. Occupational therapy – memory or cognitive problems
8. Diet
9. Ocular rehab

A Cochrane Review of Multidisciplinary Rehabilitation (MD) for the treatment of MS has been conducted to determine its effectiveness [10]. The concept of MD comprises elements of physical therapy, occupational therapy, speech pathology, psychology and or neuropsychology, cognitive therapy and or behaviour management, social work, nutrition, orthotics, counselling input, recreation and vocational therapy.

Intensity of MD rehabilitation programme was subdivided into ‘high’ or ‘low’ intensity

• High intensity therapy involved input from at least two disciplines, a minimum of thirty minutes per session and total duration of at least 2‐3 hours of interrupted therapy per day for at least 4 days per week. This is usually provided in inpatient settings and some outpatient programmes. • Low intensity programmes varied, the intensity and duration of therapy was lesser than that provided in inpatient rehabilitation settings and was dependent upon the type of rehabilitation setting and available resources From this review, it has not been possible to suggest best ‘dose’ of therapy, further studies are needed to suggest optimum number, duration and intensity of treatment sessions.

Neuropsychological rehabilitation

A Cochrane Review of neuropsychological rehabilitation (delivered by psychologists) for MS was conducted in 2014 [11]. It found that the number of intervention sessions varied from eight to 36, the duration of the rehabilitation intervention from four weeks to six months, and the frequency from two times per month to five times per week. When analysing the results with regard to the number of sessions, duration and frequency, no definite conclusions can be drawn about the effect of these factors on rehabilitation outcomes.

Exercise

Ranging from 6 to 24 weeks in duration, ranging from once to 5 times weekly frequency [12].

5 Muscular dystrophy

5.1 Clinician involved in management

Muscular dystrophy (MD) is a group of diseases that cause progressive weakness and loss of muscle mass. The most common form of MD is Duchenne’s MD which most commonly occurs in young boys. The below will be presented for Duchenne’s MD.

The care team should include a [13]:

• Neurologist with expertise in neuromuscular diseases • Physical medicine and rehabilitation specialist

Page 146 of 335

FOI 24/25-0247

• Physiotherapist • Occupational therapists. • Speech-language pathologists • Orthotist • Psychologist • Dietician.

Some people might also need a lung specialist (pulmonologist), a heart specialist (cardiologist, a sleep specialist, a specialist in the endocrine system (endocrinologist), an orthopedic surgeon and other specialists.

5.2 Best practice treatment and frequency of intervention Several types of therapy and assistive devices can improve the quality and sometimes the length of life in people who have muscular dystrophy. Examples include [13]:

• Range-of-motion and stretching exercises. Muscular dystrophy can restrict the flexibility and mobility of joints. Limbs often draw inward and become fixed in that position. Range-of- motion exercises can help to keep joints as flexible as possible.

• Exercise. Low-impact aerobic exercise, such as walking and swimming, can help maintain strength, mobility and general health. Some types of strengthening exercises also might be helpful.

o Optimal exercise modality and intensity of exercise for people with a muscle disease is still unclear. Large variation in frequency, duration and intensity exists within the literature [14-16].

• Braces. Braces can help keep muscles and tendons stretched and flexible, slowing the progression of contractures. Braces can also aid mobility and function by providing support for weakened muscles.

• Mobility aids. Canes, walkers and wheelchairs can help maintain mobility and independence.

• Psychosocial intervention

• Gastrointestinal and nutritional management Guidelines published for the diagnosis and management of Duchenne’s MD essentially states that patients should be assessed/reviewed every 6 months by allied health professionals involved in their multidisciplinary care [17].

There is no specific guidance on how many hours/visits are required for each rehabilitation intervention or clinician.

“Provide direct treatment by physical and occupational therapists, and speech-language pathologists, based on assessments and individualised to the patient.”

Page 147 of 335

FOI 24/25-0247

The above also goes for psychological assessment and intervention. The number of visits will depend on the patient’s current needs and ability to cope with their diagnosis.

6 Dementia

6.1 Clinician involved in management The needs of people with dementia vary widely and tailoring care to each person’s circumstances can be complex. A multidisciplinary approach in which different health professionals work together is important [18].

A medical specialist is required to make a dementia diagnosis. These include:

• General physicians • General practitioners • Geriatricians • Neurologists • Psychiatrists • Rehabilitation physicians

A number of different allied health professionals may be required at different points in time, including but not limited to [19]:

• Audiologists • Dentists • Dietitians • Occupational therapists • Orthoptists • Physiotherapists • Podiatrists • Psychologists • Social workers • Speech pathologists

Nurses and aged care workers are also involved in the care of patients with dementia.

6.2 Best practice treatment and frequency of intervention

Best practice care has been taken from the UK NICE guidelines on dementia [20]:

1. Person centred care a. Involving people in decision making b. Providing information c. Advance care planning
2. Care coordination a. Provide people living with dementia with a single named health or social care professional who is responsible for coordinating their care.
3. Interventions to promote cognition, independence and wellbeing

Page 148 of 335

FOI 24/25-0247

a. “Offer a range of activities to promote wellbeing that are tailored to the person’s preferences” – i.e. previous hobbies/interests b. Cognitive Stimulation for mild to moderate dementia i. Cochrane Review found that intervention ranged from 4 weeks to 24 months [21]. Median session length across the studies was 45 minutes, and the median frequency was three times a week, ranging from one to five times a week. The total possible exposure to the intervention varied dramatically, from 10 to 12 hours to 375 hours in the two‐year study. Across the 15 studies, the median exposure time was 30 hours. c. Group reminiscence therapy for mild to moderate dementia i. Cochrane Review concluded that duration and frequency of the sessions could differed. Sessions ranged from 2-8 times at either 1-2 hours (face to face or telephone) and were delivered by occupational therapists, trained recreation therapists [22]. d. Cognitive rehabilitation or occupational therapy for mild to moderate dementia i. A Cochrane Review found that intervention duration ranged from 2 to 104 weeks. Sessions ranged from 1-12 per week. More intense was classified as more than 3 formal sessions per week. Duration was 30 to 240 minutes. Those in day care facilities were often longer [23].

NOTE: The Cochrane Collaboration have undertaken various reviews of non-pharmacological interventions for dementia and found that many lack convincing evidence or well described treatment protocols. These include homeopathy, acupuncture, aromatherapy, snoezelen, validation therapy or dance movement therapy.

There is promising evidence that exercise programs may improve the ability to perform ADLs in people with dementia, although some caution is advised in interpreting these findings. Included studies were highly heterogeneous in terms of subtype and severity of participants’ dementia, and type, duration, and frequency of exercise [24].

4. Pharmacological interventions a. acetylcholinesterase (AChE) inhibitors donepezil, galantamine and rivastigmine as monotherapies are recommended as options for managing mild to moderate disease
5. Caregiver education and skills training a. A meta-analysis of 23 randomized clinical trials provides strong confirmation of the benefits of caregiver education and skills training interventions for reducing behavioural symptoms [19]. Collectively, these trials involved 3,279 community- dwelling caregivers and patients. Effective interventions were wide-ranging and included caregiver education, skills training (problem solving, communication strategies), social support (linking caregivers to others), and/or environmental modifications (assistive device use, creating a quiet uncluttered space). Interventions varied in dose, intensity, and delivery mode (telephone, mail, face-to- face, groups, computer technologies. b. Successful interventions identified included approximately nine to 12 sessions tailored to the needs of the person with dementia and the caregiver and were

Page 149 of 335

FOI 24/25-0247

delivered individually in the home using multiple components over 3–6 months with periodic follow-up [19].

While pharmacological intervention can be conveniently packaged and standardised, with a measured dose, non-pharmacological interventions can be more difficult to evaluate [25]. The same intervention may be used in different studies, but it may comprise quite different components [25]. Non-pharmacological interventions have rarely used a standardised treatment manual; mainly due to the range of individual differences between people with dementia [25].

Although some interventions can be offered for a discrete period of time, such as half an hour per day, many others involve intervention at the level of the care setting or in the general approach or interactive style of those providing care (i.e. depends on disease severity, level or care and care providers) [25].

Frequency of intervention is briefly mentioned in the Australian Clinical Practice Guidelines and Principles of Care for People with Dementia [18]. Statements include:

• Health system planners should ensure that people with dementia have access to a care coordinator who can work with them and their carer’s and families from the time of diagnosis. If more than one service is involved in the person’s care, services should agree on one provider as the person’s main contact, who is responsible for coordinating care across services at whatever intensity is required. • A care plan developed in partnership with the person and his or her carer(s) and family that takes into account the changing needs of the person. • Formal reviews of the care plan at a frequency agreed between professionals involved and the person with dementia and/or their carer(s) and family.

7 Huntington’s disease 7.1 Clinician involved in management

The multidisciplinary team assesses the stage of the disease and formulates, coordinates and implements the individual care and treatment plan and consists of [26]:

• Physician • Psychologist • Speech and language therapist • Social worker • Occupational therapist • Case manager • Psychologist • Dentist/oral health specialist

7.2 Best practice treatment and frequency of intervention

Page 150 of 335

FOI 24/25-0247

Only non-pharmacological recommendations will be presented [27]. Motor Disorders

• Chorea o Mouth guards splints. o Physiotherapy, OT, speech intervention to assess protective measures. • Dystonia o Active and passive rehabilitation with a physiotherapist to maintain range of movement. • Rigidity o Physiotherapy is recommended to improve or maintain mobility and prevent the development of contractures and joint deformity. • Swallowing disorders o Motor skills training with speech therapist. o Psychology for mood, behaviour, emotional status and cognition o Provision of information and advice by a dietician, on food textures and consistency and food modifications, bolus size and placement, safe swallowing procedures, elimination of distractions and on focusing attention on just one task at a time can help to avoid aspirations and leads to improvement of swallowing disorders. • Gait and balance disorders o Rehabilitative methods (e.g. physiotherapy and occupational therapy) may improve walking and balance disorders and prevent from their main complications (falls, fractures, loss of autonomy). Interventions for gait and balance should start as early as possible and be continued and adapted throughout the progression of the disease. o Supervised low impact exercise. • Manual dexterity o Management with physiotherapy and occupational therapy may be useful to reduce the functional impact of fine motor skill deterioration. o OT may suggest adaptive aids to compensate for the deterioration of manual dexterity (adapted cutlery, computer keyboard, adapted telephone, etc.) • Global motor capacities o Referral to a physiotherapist is recommended in order to facilitate the development of a therapeutic relationship, promote sustainable exercise behaviours and ensure long-term functional independence. Exercise programs should be personalized (considering abilities and exercise capacity), goal directed and task specific. • Cognition o Multiple rehabilitation strategies (speech therapy, occupational therapy, cognitive and psychomotricity) might improve or stabilise transitorily cognitive functions (executive functions, memory, language…) at some point of time in the course of the disease. o Cognitive stimulation • Language and communication disorders o Communication disorders in HD are variable, requires comprehensive assessment of language and of other factors such as mood, motivation and behaviour.

Page 151 of 335

FOI 24/25-0247

o Multi-disciplinary input such as Speech & Language Therapy and Physiotherapy help to retain communication and social interaction o The changing communication needs of the person with HD will be monitored and reassessed throughout the course of the disease to plan effective management strategies at all stages. • Psychiatric disorders o Based on data from other neurodegenerative conditions, mindfulness-based cognitive therapy and Acceptance and Commitment Therapy may be useful. o Underlying triggers causing changes in mood or behaviour should be addressed. o The duration of treatment is generally for over 6 months and can be for several years

*Unable to find precise data on frequency or duration of interventions for each professional.

8 Arthritis

The main treatment for arthritis is Methotrexate.

The NICE UK guidelines provides the below recommendations [28].

Non-pharmacological management

• Physiotherapy o Adults with RA should have access to specialist physiotherapy, with periodic review o Improve general fitness and encourage regular exercise  3 to 6 face to face sessions over 3-6 month period [29]. o Learn exercises for enhancing joint flexibility, muscle strength and managing other functional impairments o Learn about the short-term pain relief provided by methods such as transcutaneous electrical nerve stimulators (TENS) and wax baths. • Occupational therapy o Adults with RA should have access to specialist occupational therapy, with periodic review if they have:  Difficulties with any of their everyday activities, or  Problems with hand function. • Hand exercise programmes o Consider a tailored strengthening and stretching hand exercise programme for adults with RA with pain and dysfunction of the hands or wrists if:  They are not on a drug regimen for RA, or  They have been on a stable drug regimen for RA for at least 3 months.

The tailored hand exercise programme for adults with RA should be delivered by a practitioner with training and skills in this area.

• Podiatry o All adults with RA and foot problems should have access to a podiatrist for assessment and periodic review of their foot health needs.

Page 152 of 335

FOI 24/25-0247

o Functional insoles and therapeutic footwear should be available for all adults with RA if indicated. • Psychological interventions o Offer psychological interventions (for example, relaxation, stress management and cognitive coping skills [such as managing negative thinking]) to help adults with RA adjust to living with their condition. o Meta-analysis of psychological interventions for arthritis pain found that interventions tested were most commonly delivered in a total of nine sessions of 85 min duration, offered on a weekly or biweekly basis [30]. • Diet and complementary therapies o Inform adults with RA who wish to experiment with their diet that there is no strong evidence that their arthritis will benefit. However, they could be encouraged to follow the principles of a Mediterranean diet (more bread, fruit, vegetables and fish; less meat; and replace butter and cheese with products based on vegetable and plant oils). o Inform adults with RA who wish to try complementary therapies that although some may provide short-term symptomatic benefit, there is little or no evidence for their long-term efficacy. o If an adult with RA decides to try complementary therapies, advise them: these approaches should not replace conventional treatment.

Monitoring

Ensure that all adults with RA have:

• Rapid access to specialist care for flares • Information about when and how to access specialist care, and • Ongoing drug monitoring.

Consider a review appointment to take place 6 months after achieving treatment target (remission or low disease activity) to ensure that the target has been maintained.

Offer all adults with RA, including those who have achieved the treatment target, an annual review to:

o Assess disease activity and damage, and o Measure functional ability (using, for example, the Health Assessment Questionnaire [HAQ]). o Check for the development of comorbidities, such as hypertension, ischaemic heart disease, osteoporosis and depression. o Assess symptoms that suggest complications, such as vasculitis and disease of the cervical spine, lung or eyes. o Organise appropriate cross referral within the multidisciplinary team.

9 Chronic fatigue syndrome

Page 153 of 335

FOI 24/25-0247

9.1 Clinician involved in management

In most cases, a GP should be able to diagnose chronic fatigue syndrome (CFS). However, if, after a careful history, examination and screening investigations, the diagnosis remains uncertain, the opinion of a specialist physician, adolescent physician or paediatrician should be sought [31].

Other non-medical professionals include:

• Physiotherapists • Occupational therapists • Psychologists • Social workers • Dieticians

9.2 Best practice treatment and frequency of intervention

Care should be provided to people with CFS using a coordinated multidisciplinary approach. Based on the person’s needs, include health and social care professionals with expertise in the following [31, 32]:

• self-management strategies, including energy management • symptom management • managing flares and relapse • activities of daily living • emotional wellbeing, including family and sexual relationships • diet and nutrition • mobility, avoiding falls and problems from loss of dexterity, including access to aids and rehabilitation services • social care and support • support to engage in work, education, social activities and hobbies

No detailed information could be sourced around how many hours are required per clinician for each of these approaches. It is clearly stated that service providers should be “adapting the timing, length and frequency of all appointments to the person’s needs” [32].

There is still little evidence to support any particular management or intervention for CFS in primary care that can provide an effective early intervention [33]. The only two evidence based therapies recommended by NICE are:

• Cognitive Behavioural Therapy o Five to 16 sessions. Sessions ranged from 30 minutes to 150 minutes [34] o People with CFS should not undertake a physical activity or exercise programme unless it is delivered or overseen by a physiotherapist or occupational therapist who has training and expertise in CFS [32]. o

Page 154 of 335

FOI 24/25-0247

• Exercise Therapy o Duration of the exercise therapy regimen varied from 12 weeks to 26 weeks o three and five times per week, with a target duration of 5 to 15 minutes per session using different means of incrementation, often exercise at home [35]

10 Chronic pain

This is a very broad area. Treatments depend on location of pain. Musculoskeletal pain, particularly related to joints and the back, is the most common single type of chronic pain.

Information provided in the section on arthritis directly relates to the management of chronic pain.

A substantial systematic review by Skelly, Chou [36] investigated non-pharmacological interventions for chronic pain. Interventions that improved function and/or pain for ≥1 month included:

• Low back pain: o Exercise o Psychological therapy o Spinal manipulation o Low-level laser therapy o Massage o Mindfulness-based stress reduction o Yoga o Acupuncture o Multidisciplinary rehabilitation • Neck pain o Exercise o Low-level laser o Mind-body practices o Massage o Acupuncture • Knee osteoarthritis o Exercise o CBT • Hip osteoarthritis o Exercise o Manual therapies • Fibromyalgia o Exercise o CBT o Myofascial release massage o Mindfulness practices o Acupuncture

Page 155 of 335

FOI 24/25-0247

Substantial variability in the numbers of sessions, length of sessions, duration of treatment, methods of delivering the interventions and the experience and training of those providing the interventions present a challenge to assessing applicability [36].

The range and duration of sessions of interventions are provided below.

• Psychological therapy sessions ranged from six to eight, and the duration of therapy ranged from 6 to 8 weeks • Exercise therapy ranged from 6 weeks to 12 months, and the number of supervised exercise sessions ranged from 3 to 52. • Ultrasound therapy was 4 and 8 weeks and the number of sessions was 6 and 10. • Laser therapy ranged from 2 to 6 weeks and the number of sessions ranged from 10 to 12. • Manipulation therapy sessions ranged from 4 to 24 and the duration of therapy ranged from 4 to 12 weeks. • Massage therapy ranged from 2 to 10 weeks and the number of massage sessions ranged from 4 to 24 • Mindfulness based stress reduction 1.5 to 2 hour weekly group sessions for 8 weeks. • Yoga therapy ranged from 4 to 24 weeks and the number of sessions ranged from 4 to 48. • Acupuncture therapy ranged from 6 to 12 weeks and the number of acupuncture sessions ranged from 6 to 15. • Relaxation training and muscle performance exercise therapy were done in 30-minute sessions three times per week for 12 weeks,

11 Amputation

11.1 Clinician involved in management

The Limbs 4 Life is the peak body for amputees in Australia. They provide a list of professionals who assist with rehabilitation of amputees [37].

• Rehabilitation Consultant (doctor) o Oversees and coordinates medical care. • Occupational Therapist o Helps adjust to day to day activities like: personal care, domestic tasks such as: meal preparation, accessing your place of residence, driving, education or work readiness. If you are an upper limb amputee the occupational therapist will assist you to set goals, teach you how to perform tasks, explore modifications required to achieve goals (e.g. changes within the home or workplace), explore equipment to assist with completing tasks and assist you with the functional training of your prosthesis. • Physiotherapist o Design a tailored exercise program tailored. They will assist with balance, flexibility, strength and stamina. They will help with mobility aids such as: wheelchairs, walking frames, crutches and other assistive devices. • Prosthetist

Page 156 of 335

FOI 24/25-0247

o Will look after the design, manufacture, supply and fit of the prosthesis. Together, you will discuss and decide on the prosthetic components to suit your needs and lifestyle. • Psychologist o Supports individuals and fosters positive mental health outcomes and personal growth. • Nursing team o Assists with your medications, personal hygiene, bathing and dressing and any wound care and diabetic management that is required. • Dietitian • Podiatrist

11.2 Best practice treatment and frequency of intervention

Physiotherapy The physiotherapist progresses the patient through a programme based on continuous assessment and evaluation [38]. Through regular assessment, the physiotherapist should identify when the individual has achieved optimum function with a prosthesis, facilitating discharge to a maintenance programme.

The consensus opinion is that the physiotherapist should contribute to the management of wounds, scars, residual limb pain and phantom pain and sensation together with other members of the multidisciplinary team [38].

During prosthetic rehabilitation patients should receive physiotherapy as often as their needs and circumstances dictate [38].

Occupational therapy The occupational therapy practitioner provides critical interventions, such as [39]” • identifying the client’s functional goals, which can include self-care, home management, work tasks, driving, child care, and leisure activities, and offering modifications to complete these goals if required • analysing tasks and providing modifications to achieve functional goals • providing education on compensatory techniques and equipment to accomplish tasks and activities • providing prosthetic training • identifying and addressing psychosocial issues

Occupational therapy intervention will vary according to individual needs, and phases of intervention may overlap, depending on the person’s progress [39].

The administration of interventions for phantom limb have been shown to range between one day and 12 weeks, with one to five sessions per week [40] .

Page 157 of 335

FOI 24/25-0247

Psychology Counselling and psychological support is available to the person and their valued others preoperatively and continues as part of lifelong management [41].

Experienced clinical counselling and psychological support should be available to assist with issues such as adjustment and pain management from the acute phase, and throughout lifelong management [41].

Psychosocial issues are evaluated and addressed as part of the overall treatment plan and reviewed regularly throughout the care journey [41].

No information could be sourced about how many sessions are required.

Page 158 of 335

FOI 24/25-0247

12 References

1.  Rajan R, Brennan L, Bloem BR, Dahodwala N, Gardner J, Goldman JG, et al. Integrated Care in

Parkinson’s Disease: A Systematic Review and Meta-Analysis. Movement Disorders [Internet]. 2020 2020/09/01; 35(9):[1509-31 pp.]. Available from: https://doi.org/10.1002/mds.28097. 2. National Institute for Health and Care Excellence (NICE). Parkinson’s disease in adults. 2017. Available from: https://www.nice.org.uk/guidance/ng71/resources/parkinsons-disease-in-adults- pdf-1837629189061.

3. Tomlinson CL, Patel S, Meek C, Herd CP, Clarke CE, Stowe R, et al. Physiotherapy versus

placebo or no intervention in Parkinson’s disease. Cochrane Database of Systematic Reviews [Internet]. 2013; (9). Available from: https://doi.org//10.1002/14651858.CD002817.pub4. 4. Herd CP, Tomlinson CL, Deane KHO, Brady MC, Smith CH, Sackley CM, et al. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson’s disease. Cochrane Database of Systematic Reviews [Internet]. 2012; (8). Available from: https://doi.org//10.1002/14651858.CD002812.pub2. 5. Dixon L, Duncan DC, Johnson P, Kirkby L, O’Connell H, Taylor HJ, et al. Occupational therapy for patients with Parkinson’s disease. Cochrane Database of Systematic Reviews [Internet]. 2007; (3). Available from: https://doi.org//10.1002/14651858.CD002813.pub2. 6. The Association of UK Dieticians. Best practice guidance for dietitians on the nutritional management of Parkinson’s. 2021. Available from: https://www.parkinsons.org.uk/sites/default/files/2021- 02/Best%20practice%20guidance%20for%20dietitians%20on%20the%20nutritional%20management %20of%20Parkinson%27s%20FINAL.pdf.

7. Deane K, Whurr R, Clarke CE, Playford ED, Ben‐Shlomo Y. Non‐pharmacological therapies for

dysphagia in Parkinson’s disease. Cochrane Database of Systematic Reviews [Internet]. 2001; (1). Available from: https://doi.org//10.1002/14651858.CD002816. 8. Dix K, Green H. Defining the value of Allied Health Professionals with expertise in Multiple Sclerosis. 2013. Available from: https://support.mstrust.org.uk/file/defining-the-value-AHPs.pdf.

9.  (NICE) NIfHaCE. Multiple sclerosis in adults: management. 2019. Available from:

https://www.nice.org.uk/guidance/cg186/resources/multiple-sclerosis-in-adults-management-pdf- 35109816059077.

10. Khan F, Turner‐Stokes L, Ng L, Kilpatrick T, Amatya B. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews [Internet]. 2007; (2). Available from: https://doi.org//10.1002/14651858.CD006036.pub2.

11. Rosti‐Otajärvi EM, Hämäläinen PI. Neuropsychological rehabilitation for multiple sclerosis.

Cochrane Database of Systematic Reviews [Internet]. 2014; (2). Available from: https://doi.org//10.1002/14651858.CD009131.pub3.

Page 159 of 335

FOI 24/25-0247

12. Hayes S, Galvin R, Kennedy C, Finlayson M, McGuigan C, Walsh CD, et al. Interventions for preventing falls in people with multiple sclerosis. Cochrane Database of Systematic Reviews [Internet]. 2019; (11). Available from: https://doi.org//10.1002/14651858.CD012475.pub2.
13. Mayo Foundation for Medical Education and Research. Muscular Dystrophy 2021 [Available from: https://www.mayoclinic.org/diseases-conditions/muscular-dystrophy/symptoms-causes/syc-
15. Voet NBM, van der Kooi EL, van Engelen BGM, Geurts ACH. Strength training and aerobic exercise training for muscle disease. Cochrane Database of Systematic Reviews [Internet]. 2019; (12). Available from: https://doi.org//10.1002/14651858.CD003907.pub5.

16. Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and

management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. The Lancet Neurology [Internet]. 2018 2018/04/01/; 17(4):[347-61 pp.]. Available from: https://www.sciencedirect.com/science/article/pii/S1474442218300255. 16. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Colvin MK, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. The Lancet Neurology [Internet]. 2018 2018/05/01/; 17(5):[445-55 pp.]. Available from: https://www.sciencedirect.com/science/article/pii/S1474442218300267. 17. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurology [Internet]. 2018 2018/03/01/; 17(3):[251-67 pp.]. Available from: https://www.sciencedirect.com/science/article/pii/S1474442218300243. 18. Guideline Adaptation Committee. Clinical Practice Guidelines and Principles of Care for People with Dementia. Sydney: Guideline Adaptation Committee; 2016. Available from: https://cdpc.sydney.edu.au/wp-content/uploads/2019/06/CDPC-Dementia-Guidelines WEB.pdf.

19. Brodaty H, Arasaratnam C. Meta-Analysis of Nonpharmacological Interventions for Neuropsychiatric Symptoms of Dementia. American Journal of Psychiatry [Internet]. 2012 2012/09/01; 169(9):[946-53 pp.]. Available from: https://doi.org/10.1176/appi.ajp.2012.11101529.

20. National Institute for Health Care Excellence. National Institute for Health and Care

Excellence: Clinical Guidelines. Dementia: Assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (UK) Copyright © NICE 2018.; 2018. 21. Woods B, Aguirre E, Spector AE, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database of Systematic Reviews [Internet]. 2012; (2). Available from: https://doi.org//10.1002/14651858.CD005562.pub2. 22. Möhler R, Renom A, Renom H, Meyer G. Personally tailored activities for improving psychosocial outcomes for people with dementia in community settings. Cochrane Database of Systematic Reviews [Internet]. 2020; (8). Available from: https://doi.org//10.1002/14651858.CD010515.pub2. 23. Bahar‐Fuchs A, Martyr A, Goh AMY, Sabates J, Clare L. Cognitive training for people with mild to moderate dementia. Cochrane Database of Systematic Reviews. 2019(3). 24. Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S. Exercise programs for people with dementia. Cochrane Database of Systematic Reviews [Internet]. 2015; (4). Available from: https://doi.org//10.1002/14651858.CD006489.pub4.

Page 160 of 335

FOI 24/25-0247

25. National Collaborating Centre for Mental Health. Dementia: A NICE-SCIE guideline on

supporting people with dementia and their carers in health and social care: British Psychological Society; 2007. Dementia. 2014. 26. Veenhuizen RB, Kootstra B, Vink W, Posthumus J, van Bekkum P, Zijlstra M, et al. Coordinated multidisciplinary care for ambulatory Huntington’s disease patients. Evaluation of 18 months of implementation. Orphanet J Rare Dis [Internet]. 2011; 6:[77- pp.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253686/. 27. Bachoud-Lévi A-C, Ferreira J, Massart R, Youssov K, Rosser A, Busse M, et al. International Guidelines for the Treatment of Huntington’s Disease. Frontiers in Neurology [Internet]. 2019 2019- July-03; 10(710). Available from: https://www.frontiersin.org/article/10.3389/fneur.2019.00710. 28. National Institute for Health and Care Excellence (NICE). Rheumatoid arthritis in adults: management. 2018. 29. Peter WF, Swart NM, Meerhoff GA, Vliet Vlieland TPM. Clinical Practice Guideline for Physical Therapist Management of People With Rheumatoid Arthritis. Physical Therapy [Internet]. 2021. Available from: https://doi.org/10.1093/ptj/pzab127. 30. Dixon KE, Keefe FJ, Scipio CD, Perri LM, Abernethy AP. Psychological interventions for arthritis pain management in adults: A meta-analysis. Health Psychology [Internet]. 2007; 26(3):[241- 50 pp.]. 31. Working Group of the Royal Australasian College of Physicians. Chronic fatigue syndrome. Clinical practice guidelines–2002. Med J Aust [Internet]. 2002 May 6; 176(S9):[S17-s55 pp.]. 32. National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. 2020. Available from: https://www.nice.org.uk/guidance/gid-ng10091/documents/draft-guideline.

33. Hughes JL. Chronic Fatigue Syndrome and Occupational Disruption in Primary Care: Is There a Role for Occupational Therapy? British Journal of Occupational Therapy [Internet]. 2009 2009/01/01; 72(1):[2-10 pp.]. Available from: https://doi.org/10.1177/030802260907200102.

34. Price JR, Mitchell E, Tidy E, Hunot V. Cognitive behaviour therapy for chronic fatigue

syndrome in adults. Cochrane Database of Systematic Reviews [Internet]. 2008; (3). Available from: https://doi.org//10.1002/14651858.CD001027.pub2. 35. Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews [Internet]. 2019; (10). Available from: https://doi.org//10.1002/14651858.CD003200.pub8. 36. Skelly AC, Chou R, Dettori JR, Turner JA, Friedly JL, Rundell SD, et al. Agency for Healthcare Research and Quality: Comparative Effectiveness Reviews. 2020. In: Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US). Available from: https://www.ncbi.nlm.nih.gov/books/NBK556229/. 37. Limbs 4 Life. Your recovery 2021 [Available from: https://www.limbs4life.org.au/steps-to- recovery/your-rehabilitation-team. 38. Broomhead P, Dawes D, Hale C, Lambert A, Quinlivan D, Shepherd R. Evidence based clinical guidelines for the physiotherapy management of adults with lower limb prostheses. British Association of Chartered Physiotherapists in Amputation Rehabilitation; 2003. Available from: https://docuri.com/download/csp-guideline-bacpar 59c1cb4df581710b2860eb11 pdf.

39. Gulick K. The occupational therapy role in rehabilitation for the person with an upper-limb

amputation. American Occupational Therapy Association [Internet]. 2007. Available from:

Page 161 of 335

FOI 24/25-0247

https://www.aota.org/About-Occupational-Therapy/Professionals/RDP/upper-limb- amputation.aspx. 40. Othman R, Mani R, Krishnamurthy I, Jayakaran P. Non-pharmacological management of phantom limb pain in lower limb amputation: a systematic review. Physical Therapy Reviews [Internet]. 2018 2018/03/04; 23(2):[88-98 pp.]. Available from: https://doi.org/10.1080/10833196.2017.1412789. 41. Innovation AfC. ACI Care of the Person following Amputation: Minimum Standards of Care. Australia; 2017. Available from: https://aci.health.nsw.gov.au/ data/assets/pdf file/0019/360532/The-care-of-the-person- following-amputation-minimum-standards-of-care.pdf.

Page 162 of 335